AGP Executive Report
Last update: an hour agoBerberine “Natural Ozempic” Myth Check: A new review in the International Journal of Molecular Sciences says berberine’s effects likely come indirectly via gut inflammation, the intestinal barrier, and the microbiome—not directly like GLP-1 drugs—while also flagging digestive side effects and possible drug interactions. Cardio Risk From “Silent” Liver Changes: UK Biobank data links higher fatty liver, fibrosis, and liver function scores (FLI, FIB-4, ALBI) with a higher future cardiovascular disease risk, suggesting liver markers could help spot people headed for heart events. Commercial Insurance Role Expands: China’s National Healthcare Security Administration elevates commercial medical insurers in the 2026–2030 system, giving them a bigger seat in drug pricing and coverage decisions. Smoking Enforcement in Hong Kong: Tsim Sha Tsui crackdowns under “Cloudcrush” issued fixed penalties for illegal waterpipe and e-cigarette capsule possession in no-smoking areas. Disaster Response With Health Angle: After a Qingdao cargo ship fire killed 25, medical teams treated injured workers and burn care was mobilized as rescue operations wrapped up. ASEAN–China Health Cooperation: ASEAN and China push deeper health collaboration on resilient systems, climate and tech-driven public health threats. WHO Leadership Shake-up: Saima Wazed resigns as WHO South-East Asia Regional Director after internal scrutiny over alleged fraud and credentials.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
